Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DESMA HC Group is an Italian family-owned pharmaceutical group dating back to 1927 and operating internationally through the SIT and DESMA brands. The group manufactures and markets established therapeutic products, OTC medicines, medical devices, food supplements, cosmetics, and other healthcare products, with production sites in Italy and commercial subsidiaries across Europe. Its business model appears focused on lifecycle management and acquisition of mature branded medicines, particularly off-patent products, alongside broad international distribution. Public materials indicate the group reaches more than 70 countries across five continents and maintains a diversified portfolio spanning prescription and consumer-health segments. For a biotech analyst, this is best characterized as a commercial-stage pharmaceutical group rather than an R&D-driven biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DESMA HC Group.